Georg Stüssi

Also affiliated with Ospedale Regionale di Bellinzona e Valli

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial”.

Atezolizumab, venetoclax, and obinutuzumab combination in Richter transformation diffuse large B-cell lymphoma (MOLTO): a multicentre, single-arm, phase 2 trial

The Lancet Oncology(2024)10.1016/s1470-2045(24)00396-6

N/A

0.903DataRank · unranked

34 citations

Anna Maria Frustaci, Adalgisa Condoluci, Marta Coscia, Roberto Chiarle, Pier Luigi Zinzani +19 more

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis

Haematologica(2022)10.3324/haematol.2021.279957

N/A

0DataRank · unranked

30 citations

Sara Napoli, Luciano Cascione, Giulio Sartori, Laura Barnabei, Eugenio Gaudio +20 more

ERBB4-Mediated Signaling Is a Mediator of Resistance to PI3K and BTK Inhibitors in B-cell Lymphoid Neoplasms

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0068

N/A

0DataRank · unranked

17 citations

Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas +19 more

PI3Kδ activation, IL6 over-expression, and CD37 loss cause resistance to the targeting of CD37-positive lymphomas with the antibody-drug conjugate naratuximab emtansine

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.14.566994

N/A

0DataRank · unranked

4 citations

Eugenio Gaudio, Sara Napoli, Charles Herbaux, Chiara Tarantelli, Roberta Bordone +15 more

ERBB4-mediated signaling is a mediator of resistance to BTK and PI3K inhibitors in B cell lymphoid neoplasms

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.01.522017

N/A

0DataRank · unranked

2 citations

Sara Napoli, Luciano Cascione, Laura Barnabei, Giulio Sartori, Eleonora Cannas +19 more

PI3Kδ activation, IL-6 overexpression, and CD37 loss cause resistance to naratuximab emtansine in lymphomas

Blood Advances(2024)10.1182/bloodadvances.2023012291

N/A

0DataRank · unranked

8 citations

Sara Napoli, Eugenio Gaudio, Charles Herbaux, Eleonora Cannas, Chiara Tarantelli +16 more